MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.70 (123.14% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetActions
7/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Roth CapitalBoost Price TargetBuy$4.00 -> $5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015WedbushSet Price TargetHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015Cantor FitzgeraldSet Price TargetBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Roth CapitalLower Price TargetBuy$4.30 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2015Cantor FitzgeraldReiterated RatingBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015Roth CapitalSet Price TargetBuy$4.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Roth CapitalUpgradeNeutral -> Buy$2.30 -> $4.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Cantor FitzgeraldUpgradeHold -> Buy$2.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014Roth CapitalBoost Price TargetNeutral$1.30 -> $2.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Cantor FitzgeraldDowngradeBuy -> Hold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Roth CapitalDowngradeBuy -> Neutral$15.00 -> $1.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014RBC CapitalDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014WedbushReiterated RatingNeutral$10.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014WedbushDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014Cantor FitzgeraldBoost Price Target$8.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014Leerink SwannBoost Price TargetOutperform$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Leerink SwannBoost Price Target$10.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha